These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18813818)

  • 1. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors.
    Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Drebber U; Metzger R; Hölscher AH; Schneider PM
    Oncol Rep; 2008 Oct; 20(4):779-83. PubMed ID: 18813818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors.
    Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Lurje G; Drebber U; Metzger R; Hölscher AH; Schneider PM
    Anticancer Res; 2008; 28(1B):367-72. PubMed ID: 18383871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
    Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
    Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
    Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM; Li XH; Chen W
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between MIB-1 proliferative activity and mitotic index in gastrointestinal stromal tumors.
    Filiz G; Yalçinkaya O; Gürel S; Yerci O; Memik F
    Hepatogastroenterology; 2007 Mar; 54(74):438-41. PubMed ID: 17523292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification of patients diagnosed with gastrointestinal stromal tumor.
    Joensuu H
    Hum Pathol; 2008 Oct; 39(10):1411-9. PubMed ID: 18774375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
    Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
    Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management and clinical outcome of gastrointestinal stromal tumor of the colon and rectum.
    Chen CW; Wu CC; Hsiao CW; Fang FC; Lee TY; Che FC; Tsai WC; Jao SW
    Z Gastroenterol; 2008 Aug; 46(8):760-5. PubMed ID: 18759198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcomes and immunohistochemical features for gastrointestinal stromal tumors (GISTS) of the stomach: with special reference to prognostic factors.
    Park SS; Ryu JS; Oh SY; Kim WB; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
    Hepatogastroenterology; 2007; 54(77):1454-7. PubMed ID: 17708275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
    Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival analysis of patients with duodenal gastrointestinal stromal tumors.
    Miki Y; Kurokawa Y; Hirao M; Fujitani K; Iwasa Y; Mano M; Nakamori S; Tsujinaka T
    J Clin Gastroenterol; 2010 Feb; 44(2):97-101. PubMed ID: 19809358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors.
    Schneider-Stock R; Boltze C; Lasota J; Miettinen M; Peters B; Pross M; Roessner A; Günther T
    J Clin Oncol; 2003 May; 21(9):1688-97. PubMed ID: 12721243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
    Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of gastrointestinal stromal tumors.
    Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
    Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor.
    Hsu KH; Yang TM; Shan YS; Lin PW
    Am J Surg; 2007 Aug; 194(2):148-52. PubMed ID: 17618793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
    Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
    Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.